Combination of Bifunctional Alkylating Agent and Arsenic Trioxide Synergistically Suppresses the Growth of Drug-Resistant Tumor Cells
Drug resistance is a crucial factor in the failure of cancer chemotherapy. In this study, we explored the effect of combining alkylating agents and arsenic trioxide (ATO) on the suppression of tumor cells with inherited or acquired resistance to therapeutic agents. Our results showed that combining...
Main Authors: | Pei-Chih Lee, Rajesh Kakadiya, Tsann-Long Su, Te-Chang Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2010-05-01
|
Series: | Neoplasia: An International Journal for Oncology Research |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1476558610800557 |
Similar Items
-
Resveratrol and arsenic trioxide act synergistically to kill tumor cells in vitro and in vivo.
by: Xiao-Yan Zhao, et al.
Published: (2014-01-01) -
Use of Arsenic Trioxide as an Antivascular and Thermosensitizing Agent in Solid Tumors
by: Robert J. Griffin, et al.
Published: (2000-01-01) -
Arsenic Trioxide as a Vascular Disrupting Agent: Synergistic Effect with Irinotecan on Tumor Growth Delay in a CT26 Allograft Model
by: Jong Cheo Lee, et al.
Published: (2013-02-01) -
Arsenic trioxide and resveratrol show synergistic anti-leukemia activity and neutralized cardiotoxicity.
by: Yuhua Fan, et al.
Published: (2014-01-01) -
Arsenic Trioxide: Pharmacological Applications
by: German Madrigal Redondo, et al.
Published: (2023-04-01)